No. Nationalizing it will politicize pharmaceuticals. (and parties change control every few years of so). Private industry may chase the longevity dollars (expensive drugs for rich people who want to make their later years easier), but they also do lots of research in lots of other mundane areas.
The problem is more in the healthcare _system_ whose incentives are not aligned with the patients foremost, but rather is more geared towards extracting as much as possible from insurance companies who in turn are disincentivized to give their patients decent care, in many ways.
The problem is more in the healthcare _system_ whose incentives are not aligned with the patients foremost, but rather is more geared towards extracting as much as possible from insurance companies who in turn are disincentivized to give their patients decent care, in many ways.